IASO Bio Reports Positive MS Data for Equecabtagene at EAN Congress
IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that results...